Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections

NCT05060419 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Complicated Urinary Tract Infection
Acute Pyelonephritis

Interventions

DRUG: Meropenem- FL058
DRUG: Piperacillin -tazobactam
DRUG: Saline
DRUG: Saline

Sponsor

Qilu Pharmaceutical Co., Ltd.